Cecilia Ong, MD

Cecilia Ong, MD

General Surgery, Surgical Oncology

Accepts New Patients

Request Appointment

Please call the office to schedule an appointment with this provider.

Call the Office

Expertise of Cecilia Ong, MD

14 items. To interact with these items, press Control-Option-Shift-Right Arrow
Item 1 of 14
Biography

Cecilia Ong, MD, is a board-certified surgeon. Her specialties include:

  • Surgical Oncology
  • General Surgery
  • Gastrointestinal Cancers
  • Liver Cancer
  • Bile Duct Cancer
  • Pancreatic Cancer
  • Stomach Cancer
  • Appendix Cancer
  • Neuroendocrine Tumors
  • Peritoneal Cancer
  • Sarcomas
  • Item 2 of 14
    Care Philosophy

    Dr. Ong’s patient-centered approach and compassionate care ensures that she understands her patients' individual diagnosis, concerns and preferences working together they can develop a customized treatment plan. She believes in open communication so her patients are well informed about their procedure option(s) and expected outcomes. Dr. Ong is fellowship trained in complex cancer surgeries.

    Item 3 of 14
    Areas Served
    Hinsdale, IL | Chicago, IL
    Item 4 of 14
    Languages Spoken
    English, Vietnamese
    Item 5 of 14
    Education
    • Duke University School of Medicine
    Item 6 of 14
    Residencies
    • General Surgery at Duke University Medical Center
    Item 7 of 14
    Fellowships
    • Surgical Oncology at University of Chicago Medical Center
    Item 8 of 14
    Medical Organization Memberships and Committees
    • Americas Hepato-Pancreato-Biliary Association
    • American College of Surgeons
    • Society of Surgical Oncology

      More items loaded

    Item 9 of 14
    Board Certification
    • Surgery: The American Board of Surgery
    Item 10 of 14
    Publications
    • Bansal VV, Mitchell O, Bregio C, Witmer HDD, Dhiman A, Godley FA, Ong C, Berger Y, Reddy B, Churpek JE, Drazer MW, Eng OS, Kindler HL, Turaga KK. ASO Visual Abstract Venous Thromboembolism in Peritoneal Mesothelioma-Uncovering the Hidden Risk. Ann Surg Oncol. 2024 Mar 08. PMID 38457102.
    • Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. ASO Visual Abstract Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 01; 31(1) Call657-658-PMID 37814180.
    • Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 Jan; 31(1) Call645-654-PMID 37737968.

      More items loaded

    • Bansal VV, Witmer HDD, Lam A, Morgan RB, Godley F, Ong CT, Dhiman A, Eng OS, Turaga KK. Design and Implementation of a Learner-Centered Self-Paced Peritoneal Oncology Education Program. Ann Surg Oncol. 2023 Nov; 30(12)6983-6986. PMID 37632574.
    • Dhiman A, Kothary V, Witmer HDD, Bregio C, Sood D, Ong CT, Polite B, Eng OS, Shergill A, Turaga KK. Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery. Ann Surg. 2023 12 01; 278(6) Call925-931-PMID 36994703.
    • Morgan RB, Dhiman A, Sood D, Ong CT, Wu X, Shergill A, Polite B, Turaga KK, Eng OS. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5) Call831-840-PMID 36636792.
    • Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. ASO Visual Abstract Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 Jan; 30(1)425. PMID 36071340.
    • Sneider AP, Dhiman A, Sood D, Ong C, Tun S, Malec M, Levine S, Turaga KK, Eng OS. Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2023 03; 2831154-1160. PMID 36915007.
    • Ong CT, Schwarz JL, Roggin KK. Surgical considerations and outcomes of minimally invasive approaches for gastric cancer resection. Cancer. 2022 11 15; 128(22)3910-3918. PMID 36191278; PMCID PMC9828344.
    • Ong CT, Eng OS. ASO Author Reflections The Current Insurance Authorization Process and Future Directions for Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 01; 30(1) Call423-424-PMID 36183018.
    • Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 Jan; 30(1) Call417-422-PMID 36112250.
    • Sood D, Dhiman A, Ong CT, Liu AY, Belanski J, Turaga KK, Eng OS. The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies. Ann Surg Oncol. 2022 09; 29(9)5377-5378. PMID 35503391; PMCID PMC9063612.
    • Park TS, Thomas SM, Rosenberger LH, Fayanju OM, Plichta JK, Blitzblau RC, Ong CT, Hyslop T, Hwang ES, Greenup RA. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10)3019-3029. PMID 29978365; PMCID PMC6474911.
    • Ong CT, Campbell BM, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Force J, Hall A, Hyslop T, Hwang ES, Fayanju OM. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol. 2018 Aug; 25(8)2249-2260. PMID 29855830; PMCID PMC6039971.
    • Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK, Rosenberger LH, Hyslop T, Shelley Hwang E, Greenup RA. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011. Ann Surg Oncol. 2017 Nov; 24(12)3559-3566. PMID 28879416; PMCID PMC5994237.
    Item 11 of 14
    Ages Accepted
    • Adults
    • Geriatrics
    Item 12 of 14
    Conditions Treated
    • Appendix
    • Bile Duct Cancer
    • Gastrointestinal Cancer

      More items loaded

    • Liver Cancer
    • Neuroendocrine Tumor
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Sarcoma
    • Stomach Cancer
    Item 13 of 14
    Treatments Offered
    • AHMG da Vinci Robotic Surgery
    • AHMG Surgical Oncology
    • Appendectomy

      More items loaded

    • da Vinci Robotic Surgery
    • Gallbladder Surgery
    • Gastrointestinal Surgery
    • General Surgery
    • Inguinal Hernia Repair
    • Lung Surgery
    • Splenectomy
    • Stomach Surgery
    • Surgical Oncology
    Item 14 of 14
    Procedures and Tests
    • Appendectomy
    • Gallbladder Surgery
    • Gastrointestinal Surgery

      More items loaded

    • Inguinal Hernia Repair
    • Liver Surgery
    • Lung Surgery
    • Spleen Surgery
    • Splenectomy
    • Stomach Surgery (Gastrectomy)
    • Surgical Specialists
    • Thyroid Biopsy
    4 items. To interact with these items, press Control-Option-Shift-Right Arrow
    Question: What locations does Cecilia Ong, MD practice at?
    Answer: Cecilia Ong, MD practices at Hinsdale at 1 Salt Creek Lane, Suite 100, Hinsdale, IL, 60521, Chicago at 5841 S Maryland Ave, Chicago, IL and 60637. Learn more about Cecilia Ong, MD at AdventHealth.
    Question: What is Cecilia Ong, MD's specialty?
    Answer: Cecilia Ong, MD specializes in General Surgery and Surgical Oncology. Learn more about Cecilia Ong, MD at AdventHealth.
    Question: What conditions does Cecilia Ong, MD treat?
    Answer: Cecilia Ong, MD treats the following conditions: Appendix, Bile Duct Cancer, Gastrointestinal Cancer, Liver Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Peritoneal Cancer, Sarcoma and Stomach Cancer. Learn more about Cecilia Ong, MD at AdventHealth.
    Question: What health services does Cecilia Ong, MD provide?
    Answer: Cecilia Ong, MD provides Cancer Care and Surgical Care services. Learn more about Cecilia Ong, MD at AdventHealth.